Thiomorpholine → HCID 19438757, compound
Reaction equation
F[C:2]1[CH:11]=[C:10]2[C:5]([NH:6][C:7](=[O:16])[C:8]3[N:9]2[C:12](=[O:15])[NH:13][N:14]=3)=[CH:4][C:3]=1[N+:17]([O-:19])=[O:18].[NH:20]1[CH2:25][CH2:24][S:23][CH2:22][CH2:21]1>>[N+:17]([C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:2]=1[N:20]1[CH2:25][CH2:24][S:23][CH2:22][CH2:21]1)[N:9]1[C:12](=[O:15])[NH:13][N:14]=[C:8]1[C:7](=[O:16])[NH:6]2)([O-:19])=[O:18]Participants
3
Procedure
The title compound was prepared from 8-fluoro-7-nitro[1,2,4]triazolo[4,3-a]quinoxaline-1,4(2H,5H)-dione and thiomorpholine by a method analogous to the method described in example 11. M.p. 230° C. decomp.
Sources & evidence
- ORD record
- ord-7d60964176d840a19ed0f246006c53fd
- Source dataset
- uspto-grants-1996_07
- Patent number
- US05532236
Reaction notes
Loading…